Cognition Therapeutics EPS CGTX

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Cognition Therapeutics' earnings per share was −$0.19 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.04.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.04	n/a	−$0.19
Q1 FY26	Mar 31, 2026	−$0.05	n/a	−$0.26
Q4 FY25	Dec 31, 2025	−$0.04	n/a	−$0.35
Q3 FY25	Sep 30, 2025	−$0.06	n/a	−$0.49
Q2 FY25	Jun 30, 2025	−$0.11	n/a	−$0.68
Q1 FY25	Mar 31, 2025	−$0.14	n/a	−$0.75
Q4 FY24	Dec 31, 2024	−$0.18	n/a	−$0.88
Q3 FY24	Sep 30, 2024	−$0.25	n/a	−$0.96
Q2 FY24	Jun 30, 2024	−$0.18	n/a	−$0.93
Q1 FY24	Mar 31, 2024	−$0.27	n/a	−$0.91
Q4 FY23	Dec 31, 2023	−$0.26	n/a	−$0.85
Q3 FY23	Sep 30, 2023	−$0.22	n/a	−$0.79

Companies in Healthcare nearest Cognition Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
CGTXCognition Therapeutics	−$0.19
SPROSpero Therapeutics	$0.11
LFVNLifevantage	$0.40	−46% a year
APTAlpha Pro Tech	$0.41	+24% a year
ICCCImmucell	$0.08	−58% a year
KEQUKewaunee Scientific	$2.76	−33% a year
ATNMActinium Pharmaceuticals	$0.36
NEPHNephros	$0.16	+33% a year
PDEXPro DEX	$4.11	+52% a year
PLXProtalix BioTherapeutics	$0.23	+283% a year
NATRNatures Sunshine Products	$1.01	+36% a year
Peer median	$0.38